LL-37 (5mg)

$75.00

1 Unit
$75 per unit
$75.00
2 Units
$73.13 per unit (save 2% per unit)
$146.26
$150.00
3 Units
$71.25 per unit (save 5% per unit)
$213.75
$225.00
4 Units
$69.38 per unit (save 7% per unit)
$277.52
$300.00
5 Units
$67.5 per unit (save 10% per unit)
$337.50
$375.00
6 Units
$65.63 per unit (save 12% per unit)
$393.78
$450.00
7 Units
$63.75 per unit (save 15% per unit)
$446.25
$525.00
8 Units
$61.88 per unit (save 17% per unit)
$495.04
$600.00
9 Units
$60 per unit (save 20% per unit)
$540.00
$675.00
10 Units
$58.13 per unit (save 22% per unit)
$581.30
$750.00
Category:

Description

LL-37 is a naturally occurring human antimicrobial peptide with broad health benefits, primarily centered on immune defense, infection control, and tissue repair.

  • Antimicrobial Action: LL-37 fights a wide range of pathogens, including bacteria (e.g., MRSA, E. coli, Staphylococcus aureus), viruses (e.g., influenza, herpes), fungi (e.g., Candida), and biofilms, using a membrane-disrupting mechanism that reduces the risk of resistance.
  • Immune Modulation: It balances immune responses by recruiting immune cells, reducing pro-inflammatory cytokines, and promoting anti-inflammatory signals, helping to resolve chronic inflammation without overstimulation.
  • Wound Healing & Skin Repair: LL-37 accelerates healing by promoting angiogenesis, epithelial cell migration, collagen deposition, and re-epithelialization, making it beneficial for diabetic ulcers, burns, surgical wounds, and chronic skin conditions like eczema and acne.
  • Gut Health: Expressed in the gastrointestinal tract, it supports gut barrier integrity, reduces intestinal inflammation, and aids in recovery from leaky gut, IBD, and post-infection damage, especially when stacked with peptides like BPC-157.
  • Inflammation and Autoimmune Support: While elevated levels can contribute to autoimmunity (e.g., psoriasis, lupus), controlled LL-37 therapy can suppress excessive immune activation and promote tissue healing in immune-dysregulated conditions when used under clinical guidance.
  • Chronic Infection Management: Effective against biofilm-associated infections such as chronic Lyme disease, recurrent UTIs, and sinusitis, where conventional antibiotics fail.

LL-37 is used clinically via subcutaneous injection, topical gel, or intranasal delivery, often in combination with other peptides like BPC-157 or KPV for synergistic healing effects.  It is not FDA-approved for human use but is available by prescription in integrative medicine settings.

Related products